Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
-0.0200 (-16.67%)
At close: Feb 19, 2026
Market Cap6.77M -54.4%
Revenue (ttm)n/a
Net Income-4.57M
EPS-0.08
Shares Out67.69M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume348,707
Average Volume44,116
Open0.1200
Previous Close0.1200
Day's Range0.0750 - 0.1200
52-Week Range0.0750 - 0.3950
Beta0.08
RSI31.41
Earnings DateApr 30, 2026

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements